Conditions We
Screen For.
Florya screens for women's health conditions: PCOS, Endometriosis & Fibroids, Hormonal Health disorders, and Metabolic & Thyroid dysfunction, using internationally recognized clinical protocols.
PCOS Screening & Assessment
Polycystic Ovary Syndrome affects 8-13% of women of reproductive age, yet the average diagnostic delay is 2-4 years. Florya uses the internationally recognized Rotterdam Protocol to classify PCOS into Types A through D, correlating androgen sensitivity, ovulatory dysfunction, and metabolic markers to provide a comprehensive risk assessment.
Endometriosis & Fibroids Screening
Endometriosis affects approximately 10% of women of reproductive age, with an average diagnostic delay of 7-10 years. Florya correlates pelvic pain patterns, inflammatory markers, and reproductive history to generate an evidence-based risk score for endometriosis and uterine fibroids.
Hormonal Health Screening
Florya screens for two distinct hormonal conditions. Premature Ovarian Insufficiency (POI) — when the ovaries slow down before age 40, affecting fertility and bone health. And Hypothalamic Amenorrhea (HA) — when stress, low body weight, or excessive exercise shuts down your cycle. Both can cause missed periods, but the causes and treatments are very different.
Metabolic & Thyroid Screening
Thyroid dysfunction and insulin resistance are among the most common yet under-diagnosed conditions affecting women. Florya provides comprehensive screening for thyroid function (TSH, T3, T4) and metabolic health (HOMA-IR), identifying patterns that standard lab ranges often miss.
Your symptoms deserve clinical answers.
Completely free. Takes under 10 minutes. Your results are private, secure, and physician-ready.